ALNFL.PANFL Biosciences S.A.
Dec 15, 2026 — Phase 3 Strategic Partnership Update (NFL-101)
Chart by TradingViewThe schedule
- Tue15Dec
Window for management to secure a pharma partner to fund Phase 3 trials for NFL-101.
- Mon4Jan
Expected authorization of the Clinical Trial Application for NFL-301 in alcohol addiction.
- Sun31Jan
- Mon15Feb
High probability of equity financing if non-dilutive capital or partnerships fail to materialize.
- Thu15Apr
Full-year earnings report detailing the clinical pathway for NFL-102 and NFL-301.
- Sun2May
- Sun1Aug
- Sun31Oct
Past
- Thu22Oct
Release of half-year 2026 financial results, focusing heavily on operational cash burn.